← Open Payments lookup

LISA MEYER: Open Payments

NPI 1912208323 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,894 in 120 payments from 13 companies in 2025. Trend: 2023 $1,819 · 2024 $2,486 · 2025 $1,894

Food & beverage: $1,894
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$271
ABBVIE INC.23$250
Teva Pharmaceuticals USA, Inc.14$234
Alkermes, Inc.14$234
Neurocrine BioSciences, Inc.13$222
Vanda Pharmaceuticals Inc.11$207
Lundbeck LLC10$172
Corium, LLC8$127
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$91
E.R. Squibb & Sons, L.L.C.2$38

Products named: REXULTI, VRAYLAR, ARISTADA, INGREZZA, UZEDY, Azstarys, ABILIFY MAINTENA, FANAPT.

Industry payments across IA — which companies pay providers there.